Drug-induced liver injury — MCQs

10 questions

A 63-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has a history of hypertension, atrial fibrillation, bipolar disorder, and osteoarthritis of the knees. Current medications include lisinopril, amiodarone, lamotrigine, and acetaminophen. He started amiodarone 6 months ago and switched from lithium to lamotrigine 4 months ago. The patient does not smoke. He drinks 1–4 beers per week. He does not use illicit drugs. Vital signs are within normal limits. Examination shows no abnormalities. Laboratory studies show: Serum Na+ 137 mEq/L K+ 4.2 mEq/L Cl- 105 mEq/L HCO3- 24 mEq/L Urea nitrogen 14 mg/dL Creatinine 0.9 mg/dL Alkaline phosphatase 82 U/L Aspartate aminotransferase (AST) 110 U/L Alanine aminotransferase (ALT) 115 U/L Which of the following is the most appropriate next step in management?

A 17-year-old girl is brought to the emergency department 6 hours after she attempted suicide by consuming 16 tablets of acetaminophen (500 mg per tablet). At present, she does not have any complaints or symptoms. The patient is afebrile and vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings show a serum acetaminophen level that is predictive of ‘probable hepatic toxicity’ on the Rumack-Matthew nomogram. Treatment is started with a drug, which is a precursor of glutathione and is a specific antidote for acetaminophen poisoning. Which of the following is an additional beneficial mechanism of action of this drug in this patient?

A 55-year-old man is discharged from the hospital after being treated for a ST-elevation myocardial infarction. The patient became hypotensive to 87/48 mmHg with a pulse of 130/min. He was properly resuscitated, and a cardiac catheterization with stent placement was performed. Upon being discharged, the patient was started on metoprolol, lisinopril, aspirin, atorvastatin, and nitroglycerin. Upon presentation to the patient’s primary care doctor today, his liver enzymes are elevated with an AST of 55 U/L and an ALT of 57 U/L. Which of the following is the most likely etiology of these laboratory abnormalities?

A 35-year-old woman presents to the emergency department after ingesting approximately 50 tablets of acetaminophen 4 hours ago in a suicide attempt. Her acetaminophen level is 200 µg/mL. Which of the following best describes the mechanism of toxicity in this case?

A 57-year-old man presents to the emergency department with fatigue. He states that his symptoms started yesterday and have been worsening steadily. The patient endorses a recent weight loss of 7 pounds this past week and states that he feels diffusely itchy. The patient has a past medical history of alcohol abuse, obesity, asthma, and IV drug use. His current medications include metformin, atorvastatin, albuterol, and fluticasone. In addition, the patient admits to smoking and drinking more than usual lately due to the stress he has experienced. His temperature is 98.7°F (37.1°C), blood pressure is 130/75 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam is notable for an ill-appearing man. The patient's skin appears yellow. Abdominal exam is notable for right upper quadrant tenderness. Cardiac and pulmonary exams are within normal limits. Laboratory values are ordered as seen below: Hemoglobin: 14 g/dL Hematocrit: 42% Leukocyte count: 5,500 cells/mm^3 with normal differential Platelet count: 70,000/mm^3 Partial thromboplastin time: 92 seconds Prothrombin time: 42 seconds AST: 1110 U/L ALT: 990 U/L Which of the following is most likely to be found in this patient's history?

A 22-year-old female with a history of bipolar disease presents to the emergency room following an attempted suicide. She reports that she swallowed a bottle of pain reliever pills she found in the medicine cabinet five hours ago. She currently reports malaise, nausea, and anorexia. She has vomited several times. Her history is also notable for alcohol abuse. Her temperature is 99.4°F (37.4°C), blood pressure is 140/90 mmHg, pulse is 90/min, and respirations are 20/min. Physical examination reveals a pale, diaphoretic female in distress with mild right upper quadrant tenderness to palpation. Liver function tests and coagulation studies are shown below: Serum: Alkaline phosphatase: 110 U/L Aspartate aminotransferase (AST, GOT): 612 U/L Alanine aminotransferase (ALT, GPT): 557 U/L Bilirubin, Total: 2.7 mg/dl Bilirubin, Direct: 1.5 mg/dl Prothrombin time: 21.7 seconds Partial thromboplastin time (activated): 31 seconds International normalized ratio: 2.0 Serum and urine drug levels are pending. Which of the following medications should be administered to this patient?

A 25-year-old woman presented to an urgent care center with a complaint of a cough for more than 3 weeks that was accompanied by night sweats, weight loss, and malaise. On physical examination, the patient had slightly pale palpebral conjunctivae, bilateral posterior cervical lymphadenopathy, but with no adventitious breath sounds in the lung fields bilaterally. The remainder of the physical examination was routine. The patient was started on a drug regimen that was to be taken for 6 months. On follow-up after 2 months, the ALT and AST levels were elevated. Which of the following anti-tubercular drugs could have contributed to this laboratory result?

A 23-year-old man is admitted to the hospital for observation because of a headache, dizziness, and nausea that started earlier in the day while he was working. He moves supplies for a refrigeration company and was handling a barrel of carbon tetrachloride before the symptoms began. He was not wearing a mask. One day after admission, he develops a fever and is confused. His temperature is 38.4°C (101.1°F). Serum studies show a creatinine concentration of 2.0 mg/dL and alanine aminotransferase concentration of 96 U/L. This patient's laboratory abnormalities are most likely due to which of the following processes?

A 54-year-old man comes to the physician for a follow-up examination. One week ago, he was treated in the emergency department for chest pain, palpitations, and dyspnea. As part of his regimen, he was started on a medication that irreversibly inhibits the synthesis of thromboxane A2 and prostaglandins. Which of the following is the most likely adverse effect of this medication?

Q10

A 64-year-old woman with osteoarthritis is brought to the emergency room because of a 2-day history of nausea and vomiting. Over the past few weeks, she has been taking acetaminophen frequently for worsening knee pain. Examination shows scleral icterus and tender hepatomegaly. She appears confused. Serum alanine aminotransferase (ALT) level is 845 U/L, aspartate aminotransferase (AST) is 798 U/L, and alkaline phosphatase is 152 U/L. Which of the following is the most likely underlying mechanism of this patient's liver failure?

Drug-induced liver injury US Medical PG Practice Questions and MCQs

Question 1: A 63-year-old man comes to the physician for a routine health maintenance examination. He feels well. He has a history of hypertension, atrial fibrillation, bipolar disorder, and osteoarthritis of the knees. Current medications include lisinopril, amiodarone, lamotrigine, and acetaminophen. He started amiodarone 6 months ago and switched from lithium to lamotrigine 4 months ago. The patient does not smoke. He drinks 1–4 beers per week. He does not use illicit drugs. Vital signs are within normal limits. Examination shows no abnormalities. Laboratory studies show: Serum Na+ 137 mEq/L K+ 4.2 mEq/L Cl- 105 mEq/L HCO3- 24 mEq/L Urea nitrogen 14 mg/dL Creatinine 0.9 mg/dL Alkaline phosphatase 82 U/L Aspartate aminotransferase (AST) 110 U/L Alanine aminotransferase (ALT) 115 U/L Which of the following is the most appropriate next step in management?

A. Discontinue amiodarone (Correct Answer)
B. Discontinue acetaminophen
C. Follow-up laboratory results in 3 months
D. Follow-up laboratory results in 6 months
E. Decrease alcohol consumption

Explanation: ***Discontinue amiodarone*** * The patient has elevated **AST** and **ALT** levels, suggestive of **drug-induced liver injury**. Amiodarone is a known cause of **hepatotoxicity**, which can occur even with normal baseline liver function. * **Amiodarone-induced liver injury** can range from asymptomatic transaminase elevation to **fulminant hepatic failure**; therefore, discontinuing the drug is crucial to prevent further liver damage. *Discontinue acetaminophen* * Although **acetaminophen** can cause **hepatotoxicity** at high doses, the patient is likely taking it at therapeutic doses for osteoarthritis, as suggested by its use in routine care and the absence of overdose symptoms. * The chronic nature of amiodarone use (6 months) and its well-established risk of **liver injury** make it a more probable cause of the elevated transaminases than **therapeutic-dose acetaminophen**. *Follow-up laboratory results in 3 months* * The current **liver enzyme elevations** (AST 110 U/L, ALT 115 U/L) are significant and indicate acute liver injury. Waiting 3 months for follow-up without intervention significantly risks further liver damage. * Prompt identification and removal of the offending agent are necessary to prevent potentially irreversible **hepatic injury**. *Follow-up laboratory results in 6 months* * Delaying follow-up for 6 months is an inappropriate and potentially harmful approach given the current enzyme elevations. There is an immediate need to identify and address the cause of **liver injury**. * Such a delay could lead to progression of **liver damage**, especially if the causative agent (e.g., amiodarone) continues to be administered. *Decrease alcohol consumption* * While excessive alcohol consumption can cause **elevated liver enzymes**, the patient’s intake of 1–4 beers per week is considered light to moderate and is unlikely to be the sole cause of these significant elevations. * The presence of a known **hepatotoxic medication** (amiodarone) alongside the elevated enzymes makes the drug a much more probable cause than the patient's modest alcohol intake.

Question 2: A 17-year-old girl is brought to the emergency department 6 hours after she attempted suicide by consuming 16 tablets of acetaminophen (500 mg per tablet). At present, she does not have any complaints or symptoms. The patient is afebrile and vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings show a serum acetaminophen level that is predictive of ‘probable hepatic toxicity’ on the Rumack-Matthew nomogram. Treatment is started with a drug, which is a precursor of glutathione and is a specific antidote for acetaminophen poisoning. Which of the following is an additional beneficial mechanism of action of this drug in this patient?

A. Promotes glucuronidation of unmetabolized acetaminophen
B. Promotes microcirculatory blood flow (Correct Answer)
C. Promotes fecal excretion of unabsorbed acetaminophen
D. Prevents gastrointestinal absorption of acetaminophen
E. Promotes oxidation of N-acetyl-p-benzoquinoneimine (NAPQI)

Explanation: ***Promotes microcirculatory blood flow*** - **N-acetylcysteine** (NAC), the antidote for acetaminophen poisoning, acts as a **vasodilator** and **improves microcirculatory blood flow**, which can be beneficial in preventing and treating liver injury. - This benefit is particularly relevant in cases of severe poisoning, where compromised hepatic perfusion can exacerbate damage. *Promotes glucuronidation of unmetabolized acetaminophen* - NAC primarily works by replenishing **glutathione stores**, which are crucial for detoxifying the toxic metabolite **NAPQI**, not by enhancing glucuronidation. - Glucuronidation is a separate metabolic pathway that conjugates acetaminophen for excretion and is not directly augmented by NAC. *Promotes fecal excretion of unabsorbed acetaminophen* - NAC is given systemically (orally or intravenously) to counteract absorbed acetaminophen and does not directly promote fecal excretion of unabsorbed drug. - Activated charcoal is used to prevent absorption if given shortly after ingestion. *Prevents gastrointestinal absorption of acetaminophen* - NAC does not prevent the **Gastrointestinal absorption** of acetaminophen; it is administered after absorption has occurred and the drug is circulating in the body. - Measures like activated charcoal or gastric lavage are used to prevent absorption if the patient presents early enough. *Promotes oxidation of N-acetyl-p-benzoquinoneimine (NAPQI)* - NAC works by **reducing** the toxic metabolite **NAPQI** back to acetaminophen and by replenishing **glutathione**, which then detoxifies NAPQI. - It does not promote the *oxidation* of NAPQI; rather, it facilitates its *reduction* or conjugation to render it harmless.

Question 3: A 55-year-old man is discharged from the hospital after being treated for a ST-elevation myocardial infarction. The patient became hypotensive to 87/48 mmHg with a pulse of 130/min. He was properly resuscitated, and a cardiac catheterization with stent placement was performed. Upon being discharged, the patient was started on metoprolol, lisinopril, aspirin, atorvastatin, and nitroglycerin. Upon presentation to the patient’s primary care doctor today, his liver enzymes are elevated with an AST of 55 U/L and an ALT of 57 U/L. Which of the following is the most likely etiology of these laboratory abnormalities?

A. Metoprolol
B. Ischemic hepatitis
C. Lisinopril
D. Nitroglycerin
E. Atorvastatin (Correct Answer)

Explanation: ***Atorvastatin*** - **Statins** (like atorvastatin) are a common cause of drug-induced liver injury, manifesting as elevated liver enzymes (AST and ALT). - Regular monitoring of liver function tests is recommended when initiating or adjusting statin therapy due to this known side effect. *Metoprolol* - While metoprolol can rarely cause liver enzyme elevations, it is **much less common** and typically less pronounced than elevations seen with statins. - Its primary mechanism of action is related to beta-adrenergic blockade, not direct hepatic toxicity. *Ischemic hepatitis* - **Ischemic hepatitis**, also known as shock liver, typically causes a **much more severe and acute increase** in AST/ALT (often in the thousands), usually transiently after a hypotensive episode. - The mild, persistent elevations described after resuscitation for hypotension make drug-induced injury more likely than resolution of acute ischemic hepatitis. *Lisinopril* - **ACE inhibitors** like lisinopril can cause liver enzyme elevations, but this is a **rare adverse effect** and generally not considered a primary contributor in the context of multiple medications, especially when a statin is also prescribed. - Its hepatic side effects are overshadowed by the more common potential for hyperkalemia or angioedema. *Nitroglycerin* - **Nitroglycerin** primarily acts as a vasodilator and is **not commonly associated** with significant elevations in liver enzymes. - Its metabolism does not typically lead to hepatotoxicity as a common or dose-limiting side effect.

Question 4: A 35-year-old woman presents to the emergency department after ingesting approximately 50 tablets of acetaminophen 4 hours ago in a suicide attempt. Her acetaminophen level is 200 µg/mL. Which of the following best describes the mechanism of toxicity in this case?

A. Depletion of glutathione stores (Correct Answer)
B. Blockade of calcium channels
C. Direct cellular necrosis
D. Inhibition of cytochrome oxidase

Explanation: ***Depletion of glutathione stores*** - In acetaminophen overdose, the normal metabolic pathways become saturated, leading to the accumulation of a toxic metabolite called **N-acetyl-p-benzoquinone imine (NAPQI)**. - **NAPQI** is normally detoxified by conjugation with **glutathione**, but in overdose, glutathione stores are depleted, allowing NAPQI to bind covalently to hepatocyte macromolecules, causing damage. *Blockade of calcium channels* - This mechanism is characteristic of **calcium channel blocker toxicity**, leading to cardiovascular depression (bradycardia, hypotension) and is not relevant to acetaminophen overdose. - Acetaminophen toxicity primarily affects the liver via a different pathway, not directly interfering with calcium channels. *Direct cellular necrosis* - While acetaminophen overdose ultimately leads to **hepatocellular necrosis**, this is the *result* of the toxicity, not the primary mechanism by which the drug initiates cellular damage. - The necrosis is mediated by the accumulation of the toxic metabolite **NAPQI** and the subsequent oxidative stress and cellular injury, not by direct cellular destruction without prior steps. *Inhibition of cytochrome oxidase* - This mechanism is associated with toxins like **cyanide** and **carbon monoxide**, which impair mitochondrial respiration and cellular energy production. - Acetaminophen toxicity does not directly involve the inhibition of cytochrome oxidase as its primary mechanism of hepatotoxicity.

Question 5: A 57-year-old man presents to the emergency department with fatigue. He states that his symptoms started yesterday and have been worsening steadily. The patient endorses a recent weight loss of 7 pounds this past week and states that he feels diffusely itchy. The patient has a past medical history of alcohol abuse, obesity, asthma, and IV drug use. His current medications include metformin, atorvastatin, albuterol, and fluticasone. In addition, the patient admits to smoking and drinking more than usual lately due to the stress he has experienced. His temperature is 98.7°F (37.1°C), blood pressure is 130/75 mmHg, pulse is 90/min, respirations are 15/min, and oxygen saturation is 98% on room air. Physical exam is notable for an ill-appearing man. The patient's skin appears yellow. Abdominal exam is notable for right upper quadrant tenderness. Cardiac and pulmonary exams are within normal limits. Laboratory values are ordered as seen below: Hemoglobin: 14 g/dL Hematocrit: 42% Leukocyte count: 5,500 cells/mm^3 with normal differential Platelet count: 70,000/mm^3 Partial thromboplastin time: 92 seconds Prothrombin time: 42 seconds AST: 1110 U/L ALT: 990 U/L Which of the following is most likely to be found in this patient's history?

A. Recent antibiotic treatment with gentamicin
B. Appropriate acute management of a deep vein thrombosis
C. Decreased UDP-glucuronosyltransferase activity at birth
D. Prosthetic valve with appropriate post-operative care
E. Severe migraine headaches treated with acetaminophen (Correct Answer)

Explanation: ***Severe migraine headaches treated with acetaminophen*** - The patient's presentation with **acute liver failure** (elevated AST/ALT, coagulopathy, jaundice) in the context of increased stress and likely increased medication use, strongly suggests **acetaminophen overdose** as the cause. Given his past medical history of alcohol abuse further increases his risk of liver injury with acetaminophen. - While other etiologies such as acute viral hepatitis or ischemic hepatitis should be considered, acetaminophen overdose is the most common cause of acute liver failure. *Recent antibiotic treatment with gentamicin* - **Gentamicin** is an **aminoglycoside antibiotic** primarily associated with **nephrotoxicity** and **ototoxicity**, not acute liver failure. - Liver dysfunction is not a typical adverse effect of gentamicin, making it an unlikely cause of the patient's symptoms. *Appropriate acute management of a deep vein thrombosis* - Treatment for deep vein thrombosis typically involves **anticoagulants** such as heparin or warfarin. While these medications can rarely cause liver injury, the severe and acute elevation in liver enzymes and coagulopathy seen here points away from a standard anticoagulant side effect. - The clinical picture aligns much more closely with a direct hepatotoxic injury rather than an idiosyncratic reaction to anticoagulation. *Decreased UDP-glucuronosyltransferase activity at birth* - **Decreased UDP-glucuronosyltransferase (UGT) activity** at birth is characteristic of **Crigler-Najjar syndrome** or **Gilbert's syndrome**, which cause **unconjugated hyperbilirubinemia**. - These are typically chronic conditions that present earlier in life and do not cause acute, severe hepatocellular injury with massively elevated AST/ALT and coagulopathy. *Prosthetic valve with appropriate post-operative care* - A prosthetic heart valve, even with appropriate post-operative care, is not directly linked to acute liver failure. - While complications like endocarditis or hemolysis could cause some liver involvement, they would not typically present with this constellation of severe acute symptoms and laboratory findings.

Question 6: A 22-year-old female with a history of bipolar disease presents to the emergency room following an attempted suicide. She reports that she swallowed a bottle of pain reliever pills she found in the medicine cabinet five hours ago. She currently reports malaise, nausea, and anorexia. She has vomited several times. Her history is also notable for alcohol abuse. Her temperature is 99.4°F (37.4°C), blood pressure is 140/90 mmHg, pulse is 90/min, and respirations are 20/min. Physical examination reveals a pale, diaphoretic female in distress with mild right upper quadrant tenderness to palpation. Liver function tests and coagulation studies are shown below: Serum: Alkaline phosphatase: 110 U/L Aspartate aminotransferase (AST, GOT): 612 U/L Alanine aminotransferase (ALT, GPT): 557 U/L Bilirubin, Total: 2.7 mg/dl Bilirubin, Direct: 1.5 mg/dl Prothrombin time: 21.7 seconds Partial thromboplastin time (activated): 31 seconds International normalized ratio: 2.0 Serum and urine drug levels are pending. Which of the following medications should be administered to this patient?

A. Atropine
B. Flumazenil
C. Fomepizole
D. Physostigmine
E. N-acetylcysteine (Correct Answer)

Explanation: ***N-acetylcysteine*** - The patient's symptoms (malaise, nausea, anorexia, vomiting, RUQ tenderness), elevated transaminases (AST, ALT), hyperbilirubinemia, and coagulopathy (elevated PT/INR) following a pain reliever overdose strongly suggest **acetaminophen toxicity**. - **N-acetylcysteine (NAC)** is the antidote for acetaminophen overdose, working by replenishing **glutathione** stores and detoxifying the toxic metabolite **NAPQI**, preventing further hepatic damage. *Atropine* - **Atropine** is an anticholinergic medication used to treat bradycardia or organophosphate poisoning. - The patient's symptoms and vital signs are not consistent with cholinergic toxicity. *Flumazenil* - **Flumazenil** is a benzodiazepine receptor antagonist used to reverse the effects of **benzodiazepine overdose**. - There is no clinical indication for benzodiazepine overdose in this patient presentation. *Fomepizole* - **Fomepizole** is an alcohol dehydrogenase inhibitor used as an antidote for **methanol** or **ethylene glycol** poisoning. - While the patient has a history of alcohol abuse, her current presentation and lab findings are not consistent with methanol or ethylene glycol toxicity. *Physostigmine* - **Physostigmine** is a **cholinesterase inhibitor** used to treat anticholinergic toxicity. - The patient's symptoms and vital signs are not indicative of anticholinergic poisoning.

Question 7: A 25-year-old woman presented to an urgent care center with a complaint of a cough for more than 3 weeks that was accompanied by night sweats, weight loss, and malaise. On physical examination, the patient had slightly pale palpebral conjunctivae, bilateral posterior cervical lymphadenopathy, but with no adventitious breath sounds in the lung fields bilaterally. The remainder of the physical examination was routine. The patient was started on a drug regimen that was to be taken for 6 months. On follow-up after 2 months, the ALT and AST levels were elevated. Which of the following anti-tubercular drugs could have contributed to this laboratory result?

A. Streptomycin
B. Rifampicin
C. Ethambutol
D. Isoniazid (Correct Answer)
E. Pyrazinamide

Explanation: ***Isoniazid*** - **Isoniazid** is the **most commonly implicated** anti-tubercular drug in hepatotoxicity, particularly in the first 2 months of therapy, which matches this patient's timeline. - While **Pyrazinamide** and **Rifampicin** can also cause hepatotoxicity, **Isoniazid** causes hepatotoxicity in **10-20% of patients** with elevated transaminases and is the **most frequent single agent** responsible for drug-induced liver injury in TB treatment. - The hepatotoxicity manifests as elevated **ALT and AST levels** and can range from mild, asymptomatic enzyme elevations to severe, fatal hepatitis. - Risk factors include **fast acetylator status**, alcohol use, and concurrent use of other hepatotoxic drugs. *Rifampicin* - **Rifampicin** can cause **hepatotoxicity**, but when it occurs alone (without Isoniazid), it typically presents as a **cholestatic pattern** with elevated alkaline phosphatase and bilirubin rather than predominantly elevated transaminases. - Its primary adverse effects include **red-orange discoloration** of bodily fluids and significant drug interactions due to potent **cytochrome P450 enzyme induction**. - Hepatotoxicity from Rifampicin is **less common** than from Isoniazid when used as monotherapy. *Pyrazinamide* - **Pyrazinamide** can cause **hepatotoxicity** and is associated with elevated liver enzymes, making it a possible contributor. - However, **hepatotoxicity from Pyrazinamide** is **dose-dependent** and typically seen more with higher doses (>30 mg/kg/day) or in patients with pre-existing liver disease. - It is also associated with **hyperuricemia** and can precipitate gouty arthritis, which is not indicated in this clinical scenario. - In standard first-line therapy, **Isoniazid remains statistically more likely** to cause isolated transaminase elevation. *Streptomycin* - **Streptomycin** is an aminoglycoside antibiotic primarily known for its **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity**, rather than hepatotoxicity. - Liver enzyme elevation is **not a characteristic adverse effect** of streptomycin and is rarely reported. *Ethambutol* - **Ethambutol** is primarily associated with **optic neuritis**, leading to decreased visual acuity and red-green color blindness, which requires monitoring with regular visual acuity and color vision testing. - While mild liver enzyme elevations can rarely occur, significant **hepatotoxicity is uncommon** and not a characteristic primary adverse effect of ethambutol.

Question 8: A 23-year-old man is admitted to the hospital for observation because of a headache, dizziness, and nausea that started earlier in the day while he was working. He moves supplies for a refrigeration company and was handling a barrel of carbon tetrachloride before the symptoms began. He was not wearing a mask. One day after admission, he develops a fever and is confused. His temperature is 38.4°C (101.1°F). Serum studies show a creatinine concentration of 2.0 mg/dL and alanine aminotransferase concentration of 96 U/L. This patient's laboratory abnormalities are most likely due to which of the following processes?

A. Metabolite haptenization
B. Lipid peroxidation (Correct Answer)
C. Microtubule stabilization
D. Protoporphyrin accumulation
E. Glutathione depletion

Explanation: ***Lipid peroxidation*** - **Carbon tetrachloride (CCl4)** poisoning primarily causes liver and kidney damage through the formation of **CCl3• radical**, which triggers **lipid peroxidation** of cellular membranes. - This process leads to irreversible cell damage, manifesting as elevated liver enzymes (ALT) and kidney dysfunction (creatinine). - Lipid peroxidation is the **direct mechanism of cellular injury**, causing membrane disruption, organelle dysfunction, and cell death. *Metabolite haptenization* - While some toxins form **haptens** that can lead to immune-mediated injury, the primary mechanism of CCl4 toxicity is direct cellular damage via free radicals, not haptenization. - Haptenization typically involves a delayed hypersensitivity reaction, which is not the immediate and severe organ damage seen with CCl4. *Microtubule stabilization* - **Microtubule stabilization** is a mechanism of action for certain drugs (e.g., taxanes in chemotherapy) that interfere with cell division, but it is not a direct mechanism of toxicity for CCl4. - CCl4 toxicity is characterized by membrane damage, not disruption of the cytoskeleton. *Protoporphyrin accumulation* - **Protoporphyrin accumulation** is characteristic of certain **porphyrias** or **lead poisoning**, where there are defects in heme synthesis. - This mechanism is unrelated to the direct oxidative damage caused by CCl4 and its free radical metabolites. *Glutathione depletion* - **Glutathione (GSH)** depletion occurs early in CCl4 toxicity, reducing the cell's antioxidant capacity and allowing free radical accumulation. - However, GSH depletion is an **upstream event** that facilitates damage, while **lipid peroxidation** is the **downstream direct mechanism** that actually destroys cellular membranes and causes organ injury. - The question asks for the process causing the laboratory abnormalities (liver and kidney damage), making lipid peroxidation the more direct and accurate answer.

Question 9: A 54-year-old man comes to the physician for a follow-up examination. One week ago, he was treated in the emergency department for chest pain, palpitations, and dyspnea. As part of his regimen, he was started on a medication that irreversibly inhibits the synthesis of thromboxane A2 and prostaglandins. Which of the following is the most likely adverse effect of this medication?

A. Tinnitus
B. Gout attack
C. Chronic rhinosinusitis
D. Acute interstitial nephritis
E. Gastrointestinal hemorrhage (Correct Answer)

Explanation: ***Gastrointestinal hemorrhage*** - The medication described, which **irreversibly inhibits thromboxane A2 and prostaglandins**, is **aspirin**. Aspirin's inhibition of **prostaglandin synthesis** in the stomach reduces the protective mucous barrier, leading to an increased risk of **gastric ulcers** and **hemorrhage**. - **Thromboxane A2 inhibition** by aspirin also impairs platelet aggregation, thereby increasing the risk of bleeding, including **gastrointestinal hemorrhage**. - This is the **most common serious adverse effect** of chronic aspirin therapy, occurring in approximately 2-4% of patients on long-term low-dose aspirin for cardiovascular prophylaxis. *Tinnitus* - **Tinnitus** is a known adverse effect of **salicylate toxicity**, which usually occurs with higher doses of aspirin (>3-4 g/day). While possible, it's **uncommon with standard prophylactic doses** (81-325 mg/day) used for cardiovascular events. - The question describes a regimen for a cardiac patient, implying a therapeutic dose rather than an overdose scenario. *Gout attack* - Aspirin's effect on **uric acid excretion** is dose-dependent: low doses (<1-2 g/day) can **decrease uric acid excretion**, potentially precipitating a gout attack, while high doses increase excretion. - However, this effect is **less common** than GI complications, and aspirin is generally avoided in patients with known gout due to this complex effect and the availability of safer alternatives. *Chronic rhinosinusitis* - **Chronic rhinosinusitis** is not a direct adverse effect of aspirin. However, **aspirin-exacerbated respiratory disease (AERD)**, a condition involving asthma, nasal polyps, and chronic rhinosinusitis, can be triggered by aspirin in susceptible individuals. - This is a **rare, specific syndrome** affecting approximately 7% of adults with asthma, not a general adverse effect for all patients on aspirin. *Acute interstitial nephritis* - **Acute interstitial nephritis** is more commonly associated with **non-steroidal anti-inflammatory drugs (NSAIDs)**, which also inhibit prostaglandin synthesis, but their effect on cyclooxygenase (COX) enzymes is typically reversible, unlike aspirin. - While NSAIDs can cause AIN by acting as haptens and triggering an immune response, aspirin is **less frequently implicated** in this specific renal pathology compared to other NSAIDs.

Question 10: A 64-year-old woman with osteoarthritis is brought to the emergency room because of a 2-day history of nausea and vomiting. Over the past few weeks, she has been taking acetaminophen frequently for worsening knee pain. Examination shows scleral icterus and tender hepatomegaly. She appears confused. Serum alanine aminotransferase (ALT) level is 845 U/L, aspartate aminotransferase (AST) is 798 U/L, and alkaline phosphatase is 152 U/L. Which of the following is the most likely underlying mechanism of this patient's liver failure?

A. N-acetyl-p-benzoquinoneimine formation (Correct Answer)
B. Sulfate-conjugate formation
C. Glucuronide-conjugate formation
D. Salicylic acid formation
E. N-acetylcysteine formation

Explanation: ***N-acetyl-p-benzoquinoneimine formation*** - This patient's clinical presentation, including the history of frequent acetaminophen use, nausea, vomiting, scleral icterus, tender hepatomegaly, confusion, and significantly elevated AST/ALT levels (**845 U/L and 798 U/L respectively**), is highly indicative of **acetaminophen-induced hepatotoxicity**. - **N-acetyl-p-benzoquinoneimine (NAPQI)** is a highly reactive and toxic metabolite of acetaminophen, formed when the normal metabolic pathways (sulfation and glucuronidation) become saturated due to excessive dosing. NAPQI depletes **glutathione** stores, leading to **oxidative stress** and direct hepatocellular injury causing liver failure. *Sulfate-conjugate formation* - **Sulfate-conjugation** is one of the primary and non-toxic pathways for acetaminophen metabolism at therapeutic doses. - This pathway becomes saturated with acetaminophen overdose, leading to increased metabolism through the **cytochrome P450 pathway** and subsequent NAPQI production. *Glucuronide-conjugate formation* - **Glucuronide-conjugation** is another primary and non-toxic pathway for acetaminophen metabolism, similar to sulfation. - Like sulfation, this pathway is also saturated in cases of acetaminophen overdose, shunting more of the drug to the toxic P450-mediated pathway. *Salicylic acid formation* - **Salicylic acid** is a metabolite of aspirin (acetylsalicylic acid), not acetaminophen. - Overdose of aspirin can cause metabolic acidosis, tinnitus, and hyperthermia, but not typically the pattern of liver injury associated with this patient's findings. *N-acetylcysteine formation* - **N-acetylcysteine** is the antidote for acetaminophen overdose; it is not a metabolite of acetaminophen. - It replenishes **glutathione**, which helps detoxify NAPQI and prevent further liver damage.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free